3 ms·
The New York Times has a chart, updated daily, of all the vaccines in development.[1] This is worldwide, not US. Phase I: 24 Phase 2: 14 Phase 3: 9 Limited
by Animats 6y ago
The New York Times has a chart, updated daily, of all the vaccines in development.[1] This is worldwide, not US.
Phase I: 24
Phase 2: 14
Phase 3: 9
Limited approval: 3 (CanSinoBio, Gamaleya Research Institute (Russia), Sinovac)
Full approval: 0
That's not even including the hundred or so still in lab or animal testing. It's encouraging; something is likely to work.
The real question is, how effective are the ones that make through the safety tests? Nobody really knows yet. The FDA (pre-Trump push) announced that their minimal effectiveness for approval was 50%, which is low for a vaccine. Moderna is aiming for 60%. Effectiveness times fraction of population getting it has to be > 70% or so to stop the epidemic with a vaccine alone. That's the "herd immunity" fraction for a disease with a growth rate of 3.
Useful questions:
- If a vaccine is only partially effective, will an antibody test tell if it worked?
- Will taking one vaccine limit the effectiveness of another vaccine taken later? That's happened for a few vaccines.[2] It's usually more of a timing thing; some vaccines should not be given within a few weeks of other vaccines.[3]
- Could widespread use of a moderately effective vaccine cause people to abandon mask-type precautions and cause an epidemic spike in the unprotected part of the population?
Is someone working those issues effectively?
[1] https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html https://www.nytimes.com/interactive/2020/science/coronavirus...
[2] https://www.tandfonline.com/doi/pdf/10.1080/21645515.2015.1091908 https://www.tandfonline.com/doi/pdf/10.1080/21645515.2015.10...
[3] https://www.ok.gov/health2/documents/IMM_PRG_5-20_Intervals_Live_Vaccines&Other_Rules.pdf https://www.ok.gov/health2/documents/IMM_PRG_5-20_Intervals_...
- umanwizard 6y ago> That's the "herd immunity" fraction for a disease with a growth rate of 3. Only if you assume (1) perfectly homogeneous mixing and (2) nobody is naturally immune (either due to cross-reactivity with immune responses to other coronaviruses or for any other reason).
- brian_cloutier 6y agoTo add to this, the effective reproduction number (what I think the GP is referring to?) varies not just with the prevalence of immunity, but also with the contact network of the population in question. Currently the effective reproduction number is not 3, in most places, because we're avoiding large gatherings and, depending on the region, wearing masks and avoiding indoor gatherings. If many more people were immune, even if we hadn't reached herd immunity, we could safely relax restrictions on gatherings without causing another wave. Concerts would still be out of the question, but dinner parties and hair salons would no longer be so concerning.
- BickNowstrom 6y ago> Despite this marked difference in virus replication in the lungs, reduction in viral shedding from the nose was not observed. So vaccinated people will not get too sick, not self-isolate, but will still shed the virus? That sounds concerning for the non-vaccinated. [] ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques
- Fjolsvith 6y agoIt seems to me that right now, it is easier to identify people who are at high risk of serious infection than it is to identify people who are spreaders.
- cpeterso 6y agoIf multiple vaccines are ready at the same time, who will decide which vaccine is distributed to which people? Would it be regional? Random?
- jentist_retol 6y agoI imagine it would be constrained on shipping logistics, initially. Vaccines require temp. controlled shipping. Effectively random.
- mc32 6y agoSome are easier to make, some are more stable, some require special handling, some are more effective... it may mean different one are used according to fit.
- fuckyah 6y agoIt’s basically over in America. We’ve reached herd immunity. No need for a vaccine
- 2bitencryption 6y agoOf all the different vaccine "types" mentioned in the article (proteins, whole virus, mRNA, etc), which of those general types of vaccines are the most traditional, the most widely used, the most experimental, the most novel, etc? I'm genuinely curious if "tried and true old vaccine tech" will come out on top in this case, or if "fancy new vaccine tech" will lead the way.
- HeadsUpHigh 6y agoProteins and whole virus are the most common. mRna is new and I think at least some companies are taking advantage of the epidemic to push the technology forward.